Fantastic Hybrid Learning Opportunity!
Learn how to assess, initiate, and manage patients requiring parenteral nutrition (PN) in this hybrid continuing education course where participants learn independently through a series of videos and come together at a later date for live group case work with faculty experts via Zoom. This course is for all clinicians who care for patients needing parenteral nutrition.
Two identical sessions of the course will be offered, with the only difference being the date and time of the live case work via Zoom.
The course capacity is limited to 100 participants for each session, so register early. This small class size will be optimal for hands-on learning with the course faculty to ensure each participant completes the course with improved skills in PN order writing.
Course registrants will receive the ASPEN Parenteral Nutrition Workbook, Second Edition in both hard copy and eBook format (a $99.99 value)*.
*Participants outside the US and Canada will receive the eBook format only.
PN Order Writing Course 2024 Session 2
July 8, 2024: Independent course work begins
August 8, 2024, 2:30 - 4:00 PM ET: Live virtual case work
Session 2 has reached its capacity
LIVE CASE WORK
After completion of the online modules, participants will join faculty via Zoom for application of knowledge gained. Faculty and course participants will work collaboratively on patient cases that involve PN. Course participants will rotate between two breakout rooms to work on different cases. Each breakout room case work will last for 45 minutes for a total of 90 minutes of live case work and collaboration.
Rotation 1 will have breakout rooms focused on
Rotation 2 will have breakout rooms focused on
- Adults
- Pediatrics
- Competencies
LEARNING OBJECTIVES
- Determine when parenteral nutrition (PN) is an appropriate nutrition intervention for a given patient
- Create and write a PN prescription determining appropriate macro- and micronutrients according to the patient’s nutrition assessment including
- Initiation of PN
- Advancement to goal
- Adjustment of electrolytes based on abnormal patient laboratory values and use of medications
- Eventual weaning off PN
- Differentiate PN requirements based on patient age and clinical diagnosis
- Formulate a safe PN prescription accounting for compounding compatibility and stability limits
- Develop PN writing competencies for clinicians involved with prescribing, compounding, and administering PN
ON-DEMAND MODULES
Module | Title |
1. | PN Fundamentals |
2. | PN Safety |
3. | PN Competencies |
4. | PN Resources |
5. | PN Appropriateness |
6. | Vascular Access |
7. | PN Components |
8. | PN Administration |
9. | PN Compounding and Stability |
10. | PN Initiation and Advancement |
11. | Electrolytes |
12. | Refeeding Syndrome |
13. | PN Additives |
14. | Advancing and Monitoring PN |
15. | Additional PN Considerations |
FACULTY
Mary Petrea Cober, PharmD, BCNSP, BCPPS, FASPEN, Professor of Pharmacy Practice; Director of Workforce Development, Office of Student Success; Director of Professional Development, Office of Education, Northeast Ohio Medical University, College of Pharmacy, Rootstown, OH
Jessica Monczka, RD, CNSC, Regional Nutrition Manager for Restore+ Nutrition Program, Option Care Health, Denver, CO
Ainsley Malone, MS, RDN, LD, CNSC, FAND, FASPEN, Clinical Practice Specialist, ASPEN; Nutrition Support Dietitian, Mt. Carmel Health System, Columbus, OH
Karrie Derenski, PharmD, BCNSP, BCCCP, CNSC, DPLA, FASPEN, Assistant Director of Pharmacy Op, Department of Pharmacy, CoxHeatlh, Springfield, MO
CE Credit: 9 Credits
Level: Basic/Intermediate
Session 1 UAN: JA0002345-0000-24-098-H99-P
Session 2 UAN: JA0002345-0000-24-099-H99-P
PRICING
Individual Registration | Early SESSION 2 By July 1, 2024 | Standard SESSION 2 July 2, 2024 and after |
Members** | $279.00 | $299.00 |
Members, International* | $229.00 | $249.00 |
Non-members** | $379.00 | $399.00 |
Non-members, International* | $309.00 | $329.00 |
*International participants (outside the US and Canada) receive eBook only access to the ASPEN Parenteral Nutrition Workbook, 2nd Edition.
**Participants from US and Canada receive a hard copy of the ASPEN Parenteral Nutrition Workbook, 2nd Edition as well as eBook access. The hard copy of the PN Workbook will be shipped directly to the participant.
Cancellation/Refund Policy
Session 1
All cancellation requests must be sent to the ASPEN national office by email or fax (301-587-2365) on or before April 1, 2024. Telephone cancellations will not be accepted. Refunds will be issued less a $50.00 administrative fee. No refunds or credits will be issued for cancellations received via email or fax after April 1, 2024. Substitutions will be accepted until April 1, 2024 and will include a $50.00 administrative fee.
Session 2
All cancellation requests must be sent to the ASPEN national office by email or fax (301-587-2365) on or before July 1, 2024. Telephone cancellations will not be accepted. Refunds will be issued less a $50.00 administrative fee. No refunds or credits will be issued for cancellations received via email or fax after July 1, 2024. Substitutions will be accepted until July 1, 2024 and will include a $50.00 administrative fee.
System Requirements
Computer with internet connection
Windows or Mac OS
Supported Browsers: Firefox 100+, Chrome 100+, Safari 12+, Microsoft Edge 100+
JavaScript & Cookies enabled
Mobile Support
*Also compatible with iOS and Android-based tablets and smartphones.
Accreditation Information
Course Goal and Target Audience: The American Society for Enteral and Parenteral Nutrition (ASPEN) programs are designed for dietitians, nurses, pharmacists, physicians, and researchers who practice the sciences of clinical nutrition and metabolic support. This course is ideal for nutrition professionals such as dietitians, nurses, pharmacists, physicians, and others seeking a comprehensive course specific to parenteral nutrition and parenteral nutrition order writing.
Successful Completion: CE credit must be claimed by June 9, 2024 for Session 1 and September 8, 2024 for Session 2. To obtain credit participants must view all of the on demand recordings and participate in the live in person case work. Course evaluations must be completed in ASPEN’s eLearning Center. Certificates can be printed or stored in the eLearning Center. ASPEN submits data as required to the CPE Monitor for pharmacists. ASPEN submits physician earned CME credit to Pars. ASPEN does not submit data to any other credentialing organization.
Pharmacists and physicians, please note that ASPEN will upload earned CE credit into the appropriate system within the required timeframe. Any credit not claimed by the deadline will not be entered. Please provide your correct information when completing your evaluation and claiming your CE credit. ASPEN submits only the information that is entered by the pharmacist or physician when credit is claimed and is not responsible for following up to obtain any corrected information to ensure an error-free submission.
Accreditation Statement
In support of improving patient care, The American Society for Parenteral and Enteral Nutrition (ASPEN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
ASPEN designates this live activity for a maximum of 9 AMA PRA Category 1 Credits TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pharmacists: ASPEN designates this activity for a maximum of 9 contact hours/0.9 CEUs. Knowledge activity.
Session 1 UAN: JA0002345-0000-24-098-H99-P
Session 2 UAN: JA0002345-0000-24-099-H99-P
Nurses: ASPEN designates this activity for 9 nursing contact hours. ASPEN is approved as a provider of continuing nursing education by the California Board of Nursing, provider number CEP3970.
Dietitians: ASPEN designates this activity for 9 CPEUs.
This activity was planned by and for the healthcare team, and learners will receive 9 Interprofessional Continuing Education (IPCE) credit for learning and change.
Policies and Information:
Non-Commercialism. ASPEN subscribes to the Standards for Integrity and Independence in Accredited Continuing Education. ASPEN does not provide programs that constitute advertisement or include promotional materials. ASPEN does not endorse any products.
Privacy and Confidentiality. ASPEN respects the privacy of its members and customers. Companies that receive personal information from ASPEN to execute the business of ASPEN may use information only for that purpose.
Grievances. Grievances must be submitted in writing to Senior Director, Education and Research at ASPEN, 8401 Colesville Road, Ste 510, Silver Spring, MD 20910.
Commercial Support and Sponsorship: None.
Disclosures and Relevant Financial Relationships for Faculty
At the time of on-demand recording development, the following was disclosed.
The following individuals have no relevant financial relationships with ineligible companies: Allison Blackmer, Karrie Derenski, Ainsley Malone
M. Petrea Cober – Baxter – consultant; BBraun/CAPS – consultant; Fresenius-Kabi – consultant, relationship ended
Jessica Monczka – Fresenius Kabi – consultant, relationship ended
Disclosures will be updated prior to the live case work sessions.
ASPEN staff have no relevant financial relationships with ineligible companies.
All relevant financial relationships have been mitigated.
Note: an ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. For specific examples of ineligible companies visit accme.org/standards.
Financial relationships are relevant if the following three conditions are met for the prospective person who will control content of the education:
- A financial relationship, in any amount, exists between the person in control of content and an ineligible company.
- The financial relationship existed during the past 24 months.
- The content of the education is related to the products of an ineligible company with whom the person has a financial relationship.